Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 4
1991 3
1992 2
1993 2
1994 2
1995 1
1996 1
1997 3
1998 4
2000 1
2001 1
2002 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Results by year
Filters applied: . Clear all
Page 1
A review of the pharmacology of selegiline.
Heinonen EH, Lammintausta R. Heinonen EH, et al. Acta Neurol Scand Suppl. 1991;136:44-59. doi: 10.1111/j.1600-0404.1991.tb05020.x. Acta Neurol Scand Suppl. 1991. PMID: 1686954 Review.
Selegiline in the treatment of Parkinson's disease.
Heinonen EH, Rinne UK. Heinonen EH, et al. Acta Neurol Scand Suppl. 1989;126:103-11. doi: 10.1111/j.1600-0404.1989.tb01789.x. Acta Neurol Scand Suppl. 1989. PMID: 2515715 Review.
Selegiline in the treatment of narcolepsy.
Hublin C, Partinen M, Heinonen EH, Puukka P, Salmi T. Hublin C, et al. Among authors: heinonen eh. Neurology. 1994 Nov;44(11):2095-101. doi: 10.1212/wnl.44.11.2095. Neurology. 1994. PMID: 7969965 Clinical Trial.
Pharmacokinetics and metabolism of selegiline.
Heinonen EH, Myllylä V, Sotaniemi K, Lamintausta R, Salonen JS, Anttila M, Savijärvi M, Kotila M, Rinne UK. Heinonen EH, et al. Acta Neurol Scand Suppl. 1989;126:93-9. doi: 10.1111/j.1600-0404.1989.tb01788.x. Acta Neurol Scand Suppl. 1989. PMID: 2515726
Role of selegiline in combination therapy of Parkinson's disease.
Myllylä VV, Sotaniemi K, Mäki-Ikola O, Rinne UK, Heinonen EH. Myllylä VV, et al. Among authors: heinonen eh. Neurology. 1996 Dec;47(6 Suppl 3):S200-9. doi: 10.1212/wnl.47.6_suppl_3.200s. Neurology. 1996. PMID: 8959989 Review. No abstract available.
Selegiline as a primary treatment of Parkinson's disease.
Myllylä VV, Sotaniemi KA, Vuorinen JA, Heinonen EH. Myllylä VV, et al. Among authors: heinonen eh. Acta Neurol Scand Suppl. 1991;136:70-2. doi: 10.1111/j.1600-0404.1991.tb05023.x. Acta Neurol Scand Suppl. 1991. PMID: 1801540 Clinical Trial.
Inhibition of platelet monoamine oxidase type B by selegiline.
Heinonen EH, Anttila MI, Nyman LM, Pyykkö KA, Vuorinen JA, Lammintausta RA. Heinonen EH, et al. J Clin Pharmacol. 1997 Jul;37(7):597-601. doi: 10.1002/j.1552-4604.1997.tb04341.x. J Clin Pharmacol. 1997. PMID: 9243352 Clinical Trial.
25 results